- ►roche-diagnostics.es [PDF] AC Rosenkranz, SG Hood, RL Woods, GJ … - Diabetes, 2003 - Am Diabetes Assoc Stimulation of cardiomyocyte guanosine 3′,5′-cyclic monophosphate (cyclic
GMP) via endothelial-derived nitric oxide (NO) is an important mechanism by
which bradykinin and ACE inhibitors prevent hypertrophy. Endothelial NO ... Cited by 28 - Related articles - BL Direct - All 6 versions
- ►oxfordjournals.org A Laskowski, OL Woodman, AH Cao, GR … - Cardiovascular research, 2006 - cardiovascres.oxfordjournals.org Objective: Reactive oxygen species (ROS) such as superoxide have been linked to
the hypertrophic response of the heart to stimuli including angiotensin II
(AngII), mechanical stretch, and pressure overload. We have previously ... Cited by 20 - Related articles - All 7 versions
- ►nrc-cnrc.gc.ca [PDF] Y Ogawa, N Tamura, H Chusho, K Nakao - Canadian journal of physiology and pharmacology, 2001 - article.pubs.nrc-cnrc.gc.ca Abstract: In addition to cardiac myocyte hypertrophy, proliferation and
increased extracellular matrix production of cardiac fibroblasts occur in
response to cardiac overload. This remodeling of the cardiac interstitium ... Cited by 53 - Related articles - BL Direct - All 6 versions
- ►cardiovascres.org AC Rosenkranz, RL Woods, GJ Dusting, RH … - Cardiovascular research, 2003 - cardiovascres.org Cardiac hypertrophy develops to preserve contractile function when cardiac
workload is chronically increased [1], but in the longer term is associated with
increased cardiovascular risk [2]. At a cellular level, cardiomyocyte ... Cited by 79 - Related articles - All 6 versions
- ►ahajournals.org AC Rosenkranz, SG Hood, RL Woods, GJ … - Hypertension, 2002 - Am Heart Assoc The antihypertrophic action of angiotensin (Ang)-converting enzyme (ACE)
inhibitors in the heart is attributed in part to potentiation of bradykinin.
Bradykinin prevents hypertrophy of cultured cardiomyocytes by releasing ... Cited by 25 - Related articles - BL Direct - All 6 versions
- ►endocrinology-journals.org [PDF] T Walther, S Heringer-Walther, R Tschope, A … - Journal of Molecular Endocrinology, 2000 - Soc Endocrinology ABSTRACT C-type natriuretic peptide (CNP), a recent addition to the family of
natriuretic peptides including atrial and brain natriuretic peptide (ANP, BNP),
is believed to be an endothelium-derived vasodilator and to have an ... Cited by 18 - Related articles - BL Direct - All 5 versions
[CITATION] on behalf of the PROACTION Study Group. Nesiritide added to standard care results in …
A Bhaskaran, RM Siegel, B Barker, AW Nuttall … - Journal of Cardiac Failure, 2003 - Elsevier Background: The use of nesiritide, a recombinant form of B-type natriuretic
peptide, represents a new therapeutic approach for the treatment of
decompensated heart failure (CHF). Recent studies suggest significant ... Cited by 4 - Related articles - All 2 versions
